These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15566000)

  • 1. [Outcome of pulmonary Mycobacterium avium complex (MAC) disease treated with clarithromycin (CAM)-containing regimens].
    Shirai M; Hayakawa H; Nakano Y; Kuroishi S; Nakano Y; Todate A; Suda T; Chida K
    Nihon Kokyuki Gakkai Zasshi; 2004 Oct; 42(10):875-9. PubMed ID: 15566000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ; Wu TS; Chiang PC; Lee MH
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
    Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
    Kobashi Y; Okimoto N; Matsushima T; Shigetou E; Kuraoka T; Takeyama H; Eda R; Yano S; Kobayashi K; Ohnishi T; Mori K; Ueda Y; Moritaka T; Nishimura K; Abe T
    Kekkaku; 2002 Jun; 77(6):435-41. PubMed ID: 12136597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
    BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
    Tanaka E; Kimoto T; Tsuyuguchi K; Watanabe I; Matsumoto H; Niimi A; Suzuki K; Murayama T; Amitani R; Kuze F
    Am J Respir Crit Care Med; 1999 Sep; 160(3):866-72. PubMed ID: 10471610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
    Watanabe M; Hasegawa N; Ishizaka A; Asakura K; Izumi Y; Eguchi K; Kawamura M; Horinouchi H; Kobayashi K
    Ann Thorac Surg; 2006 Jun; 81(6):2026-30. PubMed ID: 16731124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients].
    Kuwabara K; Tsuchiya T
    Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):587-92. PubMed ID: 17763685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
    Griffith DE; Brown BA; Cegielski P; Murphy DT; Wallace RJ
    Clin Infect Dis; 2000 Feb; 30(2):288-92. PubMed ID: 10671330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
    Griffith DE; Brown-Elliott BA; Langsjoen B; Zhang Y; Pan X; Girard W; Nelson K; Caccitolo J; Alvarez J; Shepherd S; Wilson R; Graviss EA; Wallace RJ
    Am J Respir Crit Care Med; 2006 Oct; 174(8):928-34. PubMed ID: 16858014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.
    Komiya K; Kurashima A; Ihi T; Nagai H; Matsumoto N; Mizunoe S; Ishii H; Takahashi O; Ohta K; Kudoh S; Kadota J
    Int J Antimicrob Agents; 2014 Aug; 44(2):131-5. PubMed ID: 24948577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical study of clarithromycin for pulmonary Mycobacterium avium-intracellulare complex infection].
    Yamamoto M; Kuze F; Sakatani M; Saito H; Shimoide H; Soejima R; Hara K
    Kekkaku; 1997 Jan; 72(1):1-7. PubMed ID: 9038009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic efficacy of macrolide in pulmonary nontuberculous mycobacteriosis].
    Tomono K
    Kekkaku; 1994 Nov; 69(11):725-32. PubMed ID: 7837727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
    Hasegawa N; Nishimura T; Ohtani S; Takeshita K; Fukunaga K; Tasaka S; Urano T; Ishii K; Miyairi M; Ishizaka A
    Chest; 2009 Dec; 136(6):1569-1575. PubMed ID: 19542259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease.
    Ito Y; Hirai T; Maekawa K; Fujita K; Imai S; Tatsumi S; Handa T; Matsumoto H; Muro S; Niimi A; Mishima M
    Int J Tuberc Lung Dis; 2012; 16(3):408-14. PubMed ID: 22230733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and outcomes of clarithromycin treatment for pulmonary MAC disease.
    Fujikane T; Fujiuchi S; Yamazaki Y; Sato M; Yamamoto Y; Takeda A; Nishigaki Y; Fujita Y; Shimizu T
    Int J Tuberc Lung Dis; 2005 Nov; 9(11):1281-7. PubMed ID: 16333938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
    Koh WJ; Jeong BH; Jeon K; Lee SY; Shin SJ
    Am J Respir Crit Care Med; 2012 Oct; 186(8):797-802. PubMed ID: 22878282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y; Tsuyuguchi K; Kobayashi T; Kurahara Y; Yoshida S; Kagawa T; Hayashi S; Suzuki K
    J Infect Chemother; 2020 Jul; 26(7):676-680. PubMed ID: 32171660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.